Zantac Attorneys Pursuing Cancer Claims Across Florida, Illinois, and Beyond

What the FDA's Recall Revealed About Zantac

A cancer diagnosis can change every part of your life. When that diagnosis follows years of taking a medication you trusted, you may have questions about whether someone else should be held responsible. Nessler & Associates has represented injured people since 1977, helping clients pursue accountability when corporations and manufacturers fail to put safety first.

If you developed cancer after taking Zantac or its generic form, ranitidine, we can review your situation and determine whether you may have a claim. We represent clients in Florida, Illinois, Texas, Missouri, Kentucky, and Colorado on a contingency fee basis, meaning there are no attorney fees unless we recover compensation for you.

Why Zantac Was Recalled

Zantac was the brand name for ranitidine, a medication prescribed and sold over the counter for decades to treat heartburn, acid reflux, and ulcers. The concern surrounding Zantac was not its intended purpose, but the potential presence of N-nitrosodimethylamine (NDMA).

Ranitidine has an unstable molecular structure that can break down and produce NDMA under certain conditions. The International Agency for Research on Cancer classifies NDMA as a probable human carcinogen. After testing raised concerns about NDMA levels in ranitidine products, Amneal Pharmaceuticals voluntarily recalled ranitidine products in 2019. On April 1, 2020, the FDA requested the removal of all ranitidine products from the U.S. market.

Sanofi's Record Before the Recall

Sanofi, one of the companies associated with Zantac, faced regulatory issues before the FDA recall. In 2012, Sanofi reached a $109 million settlement involving allegations under the False Claims Act. In 2018, the company settled Foreign Corrupt Practices Act violations for more than $25 million.

When pursuing a pharmaceutical injury claim, the focus is not only on the injury itself. A major part of these cases involves examining what a manufacturer knew about potential risks, when that information became available, and whether it provided adequate warnings.

Cancer Types Associated With Zantac and Ranitidine Claims

NDMA exposure has been studied in connection with multiple forms of cancer. Zantac and ranitidine lawsuits have involved claims involving:

• Bladder cancer

• Esophageal cancer

• Stomach cancer

• Pancreatic cancer

• Liver cancer

• Kidney cancer

• Lung cancer

• Breast cancer

• Intestinal cancer

• Ovarian cancer

• Thyroid cancer

• Colorectal cancer

• Prostate cancer

A cancer diagnosis alone doesn’t automatically mean you have a valid Zantac claim. These cases require a review of your medical history, documented ranitidine use, diagnosis, and other factors that may affect whether a legal claim is available.

For more information about pharmaceutical injury claims, view our product liability attorney practice area.

Zantac Lawsuits vs. Class Actions: Understanding the Difference

Zantac claims aren’t handled as a traditional class action lawsuit. Instead, these cases proceed through multidistrict litigation, commonly called an MDL.

An MDL allows similar cases involving the same drug and legal issues to be coordinated in one federal court for efficiency. However, each person's claim remains separate. Your potential recovery depends on your diagnosis, medical history, losses, and circumstances.

This distinction matters because serious injuries require individual consideration. A person's experience with Zantac, their cancer diagnosis, and the impact on their family are not the same as another claimant's situation.

What a Zantac Cancer Lawsuit May Be Worth

There is no set value for a Zantac cancer claim. Potential compensation depends on many factors, including:

• The type and stage of cancer

• The duration and amount of ranitidine use

• Medical expenses related to treatment

• Lost income or reduced earning ability

• The effect the illness has had on your daily life

At Nessler & Associates, we evaluate each claim individually and work to understand the full impact an injury has had on your life. You can learn more about our experience representing injured clients through our case results.

How Nessler & Associates Pursues Zantac Claims

The process begins with a free consultation. We take the time to understand what medication you took, when you took it, your diagnosis, and how your health has been affected.

If we determine you may have a viable claim, our attorneys handle the legal process, including reviewing medical information, gathering supporting documentation, and pursuing your case within the MDL process.

You do not have to navigate complex pharmaceutical litigation alone. Our team provides direct communication and straightforward guidance while pursuing accountability on your behalf. Learn more about our broader injury practice on our personal injury page.

States Where We Pursue Zantac Claims

Nessler & Associates represents clients pursuing Zantac and ranitidine cancer claims in:

• Florida

• Illinois

• Texas

• Missouri

• Kentucky

• Colorado

Because these cases proceed through federal multidistrict litigation, the process is not limited to where the lawsuit was originally filed. However, your state of residence may affect important issues such as deadlines and procedural requirements. Our Largo, Florida, and Springfield, Illinois locations serve two of the firm's active markets.

Talk to a Zantac Attorney About Your Cancer Diagnosis

If you or a loved one developed cancer after taking Zantac or ranitidine, Nessler & Associates can review your situation and explain your legal options. Our attorneys have represented injured clients for decades and understand the importance of holding companies accountable when their decisions harm people. Your initial consultation is free, and there are no attorney fees unless we recover compensation for you.